# EDGAR Filing Document

**Accession Number:** 0001816736
**File Stem:** 0001193125-23-011982
**Filing Date:** 2023-1
**Character Count:** 2066
**Document Hash:** 39b1bf39bad32888ac5f004665049b34
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-011982.hdr.sgml**: 20230222

**ACCESSION NUMBER**: 0001193125-23-011982

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230120

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Disc Medicine, Inc.
- **CENTRAL INDEX KEY:** 0001816736
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 851613057
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 300 ONE KENDALL SQUARE, 3RD FLOOR
- **CITY:** CAMBRIDGE
- **STATE:** MA
- **ZIP:** 02139
- **BUSINESS PHONE:** (617) 401-4400

**MAIL ADDRESS:**
- **STREET 1:** 300 ONE KENDALL SQUARE, 3RD FLOOR
- **CITY:** CAMBRIDGE
- **STATE:** MA
- **ZIP:** 02139

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Gemini Therapeutics, Inc. /DE
- **DATE OF NAME CHANGE:** 20210209

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FS Development Corp.
- **DATE OF NAME CHANGE:** 20200702

Disc Medicine, Inc.

321 Arsenal Street, Suite 101

Watertown, MA 02472

January 20, 2023

**<u>VIA EDGAR</u>**

Securities and Exchange Commission

Division of Corporation Finance – Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Re: Disc Medicine, Inc. Registration Statement on Form S-3 File No. 333-269270 <u>Request for Acceleration</u>

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Disc Medicine, Inc. (the "Company") hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-269270) (the "Registration Statement"), so that it may become effective at 4:01 pm Eastern time on January 24, 2023, or as soon thereafter as practicable.

---

| | |
|:---|:---|
|  Very truly yours,<br>DISC MEDICINE, INC. | Very truly yours,<br>DISC MEDICINE, INC. |
|  By: | /s/ John Quisel |
|  | Name: John Quisel, J.D., Ph.D.<br> Title: Chief Executive Officer |

---

Cc: William Collins, Goodwin Procter LLP